News Conference News ACC 2012 BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy Jason Kahn March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding L.A. McKeown March 24, 2012